Variables | IgG Titer (EU) | P | IgA Titer (EU) | P | |
---|---|---|---|---|---|
Age (n(%)) | ≤ 60(26(32.5%) | 132.15 ± 62.13 | 0.46 | 31.54 ± 25.93 | 0.52 |
> 60(54(67.5%)) | 121.07 ± 62.65 | 38.23 ± 49.45 | |||
Gender (n(%)) | Male(55(68.8%)) | 127.80 ± 62.18 | 0.51 | 37.52 ± 48.10 | 0.65 |
Female(25(31.2%)) | 116.77 ± 63.30 | 32.84 ± 30.22 | |||
Tobacco use (n(%)) | No(43(%)) | 122.62 ± 58.81 | 0.75 | 34.52 ± 30.12 | 0.73 |
Yes(37(%)) | 127.05 ± 66.87 | 37.84 ± 55.00 | |||
Alcohol use (n(%)) | No(74(%)) | 125.57 ± 63.66 | 0.65 | 61.30 ± 74.42 | 0.60 |
Yes(6(%)) | 113.47 ± 44.82 | 54.28 ± 25.41 | |||
Differentiation grade (n(%)) | Well(17(21.2%)) | 166.72 ± 71.77 | 0.15 | 36.47 ± 36.07 | 0.83 |
Moderately(47(58.8%)) | 105.27 ± 45.26 | 35.12 ± 49.55 | |||
Poorly(15(18.8)) | 140.28 ± 72.94 | 40.17 ± 29.95 | |||
T stage (n(%)) | T1 + T2(17(21.5%)) | 121.72 ± 48.57 | 0.80 | 27.17 ± 20.14 | 0.33 |
T3 + T4(62(78.5%)) | 126.08 ± 66.19 | 38.89 ± 47.61 | |||
Lymph node metastasis (n(%)) | No(44(56.4%)) | 115.07 ± 57.03 | 0.19 | 42.94 ± 57.45 | 0.27 |
Yes(34(43.6%)) | 134.05 ± 66.21 | 31.97 ± 28.31 | |||
TNM stage (n(%)) | I–II(51(63.8%)) | 130.18 ± 62.58 | 0.34 | 31.77 ± 27.59 | 0.21 |
III–IV(28(36.2%)) | 115.95 ± 62.60 | 44.73 ± 62.51 |